Kevin Kavanagh’s Post

🌍 Transforming Liver Disease Care with Remote Patient Monitoring 🌍 Liver disease is a growing health challenge, contributing to thousands of hospital admissions each year. Partnering with Barts Health NHS Trust Doccla’s Remote Patient Monitoring (RPM) solution is helping improve patient outcomes and ease pressures on the NHS. ✨ Key Outcomes from Our Latest Case Study: • 50% Reduction in Liver-Related Mortality at 90 Days: Patients monitored through RPM experienced half the liver-related deaths compared to those receiving standard care. • 57% Fewer Emergency Admissions: RPM patients had a significant reduction in emergency admissions, underscoring the impact of proactive care. • 29% Reduction in Decompensated Cases at 30 Days Together with Barts, Doccla is empowering patients and clinicians to manage liver disease through innovative, resource-optimising solutions. 🚀 Discover more about our journey and outcomes here: https://lnkd.in/eg8xjjeR #HealthcareInnovation #RemotePatientMonitoring #LiverDisease #NHS #Doccla #BartsAndRoyalLondon #PatientCare #HealthcareTransformation

MDs' One-Word Summary of Long COVID Progress: 'Frustration' By Solarina Ho Stuart Malcolm, MD, a primary care physician who practices in Oregon and northern California, started seeing patients with long COVID early in the pandemic. Back then, he was frustrated by the obstacles and lack of standard diagnostic tests and treatments. Four years later, well, he still is. "Something I learned the last few years is the logistics to get people care is really, really hard," he said. "There's a lot of frustration. It's mostly frustration." For long COVID doctors and patients, there has been little to no progress addressing the challenges, leaving many discouraged. Researchers and clinicians now have a greater understanding of what health agencies formally call post-COVID condition, but the wide spectrum of symptoms, slow progress in launching pharmacologic clinical trials, and the research toward understanding the underlying causes mean standardized diagnostic tests and definitive treatments remain elusive. "The frustration is that we aren't able to help everyone with our current knowledge base. And I think the frustration lies not just with us physicians but also with patients because they're at the point where if they tried everything, literally everything and haven't gotten better," said Zijian Chen, MD, director of the Mount Sinai Center for Post-COVID Care in New York City. Wanted: More Funding, More Doctors, More Clinics Between 10% and 20% of the estimated hundreds of millions of people infected worldwide with SARS-CoV-2 in the first 2 years went on to develop long-term symptoms. While many recover over time, doctors who have treated long COVID since 2020 said they see some patients still wrestling with the condition after 4 years. The latest Centers for Disease Control and Prevention Household Pulse Survey, taken between March 5 and April 1, 2024, estimated that nearly 7% of the adult population — more than 18 million people — currently have long COVID. Data from other countries also suggest that millions have been living with long COVID for years now, and hundreds of thousands have seen their day-to-day activities significantly affected. ***Please click on the banner below to access and finish reading this piece. Posted by Larry Cole

Blood clots, particularly deep vein thrombosis and pulmonary embolism, together venous thromboembolism, pose a significant health threat to patients. These potentially life-threatening conditions can manifest silently and without warning, making vigilance and knowledge crucial. To mark World Thrombosis Day, we have pulled together resources, blogs and reports from the hub for patients and healthcare professionals, which focus on how to recognise venous thromboembolism and how to improve patient safety. This article includes resources and information Thrombosis UK, Jo Jerrome, Health Services Safety Investigations Body (HSSIB), NHS Resolution and Professors Beverley Hunt OBE. Link: https://lnkd.in/eCGnW3yu #WorldThrombosisDay #WTDay24 #pslhub #patientsafety #thrombosis #venousthromboembolism #deepveinthrombosis #pulmonaryembolism #avoidableharm #diagnosticsafety

An excellent collection of information & resources to support blood clot prevention, detection and understanding. Well done Patient Safety Learning

🚨 New Insights into Catheter Care: Prophylactic Washouts Show Promise! 🚨 In the quest for enhanced patient outcomes in long-term catheter (LTC) care, a recent UK study has unveiled promising results regarding the use of prophylactic saline and acidic washouts. 🔍 Key Findings: - Reduced Catheter Blockages: The study revealed that washout interventions led to significantly lower rates of catheter blockages compared to standard care. - Improved Patient Safety: The saline washout group demonstrated a notable decrease in symptomatic catheter-associated urinary tract infections (S-CAUTI). While the findings are encouraging, further multinational trials are essential to confirm these benefits and assess their cost-effectiveness. This research highlights the importance of integrating innovative strategies into LTC protocols for better patient quality of life and reduced healthcare costs. 👉 Click on the embedded link to explore more about this groundbreaking study! #CatheterCare #ClinicalResearch #HealthTechnologyAssessment #HealthcareInnovation #LTCManagement #PatientSafety #Publications #MarketAccess #MarketAccessToday

Ballooning chronic disease rates require rethinking hospitalization This article raises several interesting valid points, highlighting that today's healthcare model focuses on episodic care, including the reason for hospitalization, generally one or two acute diagnoses. The MS-DRG system perpetuates the focus and concentration on acute diagnoses with those diagnoses impacting reimbursement, CC/MCCs, being documented. The physician should take a "holistic" approach to the management of the patient, taking into account other chronic conditions such as Parkinsonism discussed in the article. How often do we see documented in the record a list of chronic conditions with the plan of care to continue outpatient meds? The downside is that payers do not acknowledge chronic conditions, their focus is on the acute clinical conditions that can be plugged into MCG or Interqual and make an authorization decision of Observation vs Inpatient. Chronic conditions that do not directly impact the management of the patient's acute conditions are discounted. "By adopting a more proactive mindset, we can provide safer care for our patients during their hospitalization, while guiding them toward better health outcomes once they're discharged. Along the way, we can reimagine and redefine what a hospitalization can be. As a healthcare industry, we have ample room for improvement when it comes to factoring in a patient's chronic disease status into hospital care." Payers are in the driver's seat. #holisitic, #chronicconditions, ##costeffectivecare, #betterfortthepatient, #changingthefocus https://lnkd.in/eHjgsUvU

Implementation of Sweden's first digi-physical hospital-at-home care model for high-acuity patients In a study published in The Journal of Telemedicine and Telecare, Mikael Kastengren (Co-Founder and Chief Research Officer at Medoma), Linda Frisk, Linda Winterfeldt, Gunilla Wahlström, and Magnus Dalén present results from the launch of Sweden's first digi-physical virtual inpatient department. The patient base consisted of adult patients with acute medical conditions requiring hospital care. These patients were offered care at a virtual inpatient department as an alternative to traditional inpatient care. The main objective was to measure patient satisfaction. Other outcomes evaluated included patient safety and quality, among others. With high values of patient satisfaction and quality of care, the results show a successful model for future healthcare. This research marks an important step forward in the quest to improve accessibility and efficiency in the healthcare system, and its results significantly contribute to the scientific literature in the field. Data from the study: Number of patients in the study (Oct 2022 to June 2023): 200 Number of medical conditions: 63 Most common diseases: Infectious diseases (44%) and pulmonary diseases (17%) Mortality: 0 Hospital-related complications: 0 Transfers to hospital: 11 (5.5%) Patient satisfaction: NPS 88 #näravård #hospitalathome https://lnkd.in/d-mwPT7p

Earlier today HHS released new considerations for providers who test patients for syphilis. The Considerations for the Implementation of Point of Care Tests for Syphilis resource outlines four main differences between syphilis point of care tests and laboratory-based serologic syphilis tests and highlights the best settings to consider use of point-of-care tests. Additionally, this resource examines point of care testing program implementation and management, provides answers to common questions, and lists links to related resources. Read the Considerations for the Implementation of Point of Care Tests for Syphilis Resource: https://brnw.ch/21wKHo6. Please consider joining us for the Stopping Syphilis: The HHS Summer Seminar Series. The first webinar in the series will focus on considerations for syphilis point of care testing. Register for the first webinar in the Stopping Syphilis: The HHS Summer Seminar Series: https://brnw.ch/21wKHo5

In recent years, after the end of the corona pandemic, people struggling with post-COVID symptoms had few places to turn to with their complaints. Initially there was hardly any attention for this 'consequential disease', but fortunately that is changing. More and more research into post-COVID has already been done recently, and soon three University Medical Centres will open the Netherlands' first post-COVID expertise centers for adults. Maastricht UMC+ Erasmus MC Amsterdam UMC #covid #healthcare

It was an honor for me to be involved in this project. In the updated systematic review and meta-analysis, we realized that: PPIs decrease upper GI bleeding in ICU admitted patients. PPIs may have little or no effect on overall mortality in ICU admitted patients, though a decrease in mortality in less severely ill patients and an increase in mortality in more severely ill patients remain possible. Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation | https://lnkd.in/g6bNj9WE #Proton_Pump_Inhibitors #GI_Bleeding #NEJM #NEJM_Evidence #REVISE_trial McMaster University Department of Health Research Methods, Evidence, and Impact NEJM Evidence